Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Brandon Capital Partners

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 40
Average round size
The average size of a deal this fund participated in
Portfolio companies 29
Rounds per year 2.50
Lead investments 5
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Therapeutics

In 2006 was created Brandon Capital Partners, which is appeared as VC. The leading representative office of defined VC is situated in the Melbourne. The company was established in Australia.

The top amount of exits for fund were in 2018. The high activity for fund was in 2016. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Brandon Capital Partners performs on 17 percentage points less the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually.

Besides them, we counted 6 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Brandon Capital Partners, startups are often financed by Split Rock Partners, Delphi Ventures, Uniseed Ventures. The meaningful sponsors for the fund in investment in the same round are Uniseed Ventures, GBS Ventures, Terra Rossa Capital. In the next rounds fund is usually obtained by Medical Research Commercialisation Fund (MRCF), Kohlberg Kravis Roberts, Uniseed Ventures.

Among the most popular portfolio startups of the fund, we may highlight EBR Systems, Signostics, MecRx. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Australia. We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. The fund has exact preference in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Brandon Capital Partners:
Typical Co-investors
Brandon Capital Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Brandon Capital Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Australia
Funds with similar focus located in Australia:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NRG Therapeutics

$21M09 Nov 2022 Cambridge, Cambridgeshire, United Kingdom

Pheon Therapeutics

Life Science
$68M28 Sep 2022 London, England, United Kingdom

OncoRes Medical

Health Care
Medical Device
$6M18 May 2022 Australia, Western Australia, Australia

Ankere Therapeutics

$7M03 May 2022 -

Allay Therapeutics

$60M15 Sep 2021 Menlo Park, California, United States

Ena Respiratory

Health Diagnostics
$23M17 Jun 2021 Melbourne, Victoria, Australia

Myricx Pharma

Life Science
$6M16 Nov 2020 United Kingdom, England, United Kingdom

Ena Respiratory

Health Diagnostics
$8M28 Sep 2020 Victoria


Health Care
$10M26 Sep 2019 Victoria


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Brandon Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: